Literature DB >> 22426625

Co-existing chronic myeloid leukaemia and multiple myeloma: rapid response to lenalidomide during imatinib treatment.

C Offiah, J P Quinn, P Thornton, P T Murphy.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22426625     DOI： 10.1007/s12185-012-1038-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  Multiple myeloma preceding the development of chronic myelogenous leukemia.

Authors:  M Nitta; K Tsuboi; S Yamashita; M Kato; Y Hayami; S Harada; H Komatsu; S Iida; S Banno; A Wakita; R Ueda
Journal:  Int J Hematol       Date:  1999-04       Impact factor: 2.490

2.  Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: evaluation by FISH analysis and in vitro expansion of bone marrow cells.

Authors:  J D Schwarzmeier; M Shehata; J Ackermann; M Hilgarth; H Kaufmann; J Drach
Journal:  Leukemia       Date:  2003-07       Impact factor: 11.528

Review 3.  Uncommon case of chronic myeloid leukemia with multiple myeloma.

Authors:  Masaru Ide; Nobuo Kuwahara; Eijo Matsuishi; Shinya Kimura; Hisashi Gondo
Journal:  Int J Hematol       Date:  2010-03-30       Impact factor: 2.490

4.  Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies.

Authors:  Dushyant Verma; Hagop Kantarjian; Sara S Strom; Mary Beth Rios; Elias Jabbour; Alfonso Quintas-Cardama; Srdan Verstovsek; Farhad Ravandi; Susan O'Brien; Jorge Cortes
Journal:  Blood       Date:  2011-08-16       Impact factor: 22.113

5.  Development of multiple myeloma in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate for 65 months.

Authors:  Michalis Michael; Marios Antoniades; Elena Lemesiou; Nicandros Papaminas; Freiderikh Melanthiou
Journal:  Oncologist       Date:  2009-12-02

Review 6.  Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature.

Authors:  M Tanaka; R Kimura; A Matsutani; K Zaitsu; Y Oka; K Oizumi
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195
  6 in total
  5 in total

1.  A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinib.

Authors:  Samer Alsidawi; Abhimanyu Ghose; Julianne Qualtieri; Neetu Radhakrishnan
Journal:  Case Rep Oncol Med       Date:  2014-12-02

2.  Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.

Authors:  J Maerki; G Katava; D Siegel; J Silberberg; P K Bhattacharyya
Journal:  Case Rep Hematol       Date:  2014-10-15

3.  Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib.

Authors:  Naveed Ali; Peter V Pickens; Herbert E Auerbach
Journal:  Hematol Rep       Date:  2016-03-17

4.  A case of synchronous multiple myeloma and chronic myeloid leukemia.

Authors:  Ji-Young Lee; Sang-Min Lee; Hye-Kyoung Yoon; Ki-Hyang Kim; Moon-Young Choi; Won-Sik Lee
Journal:  Blood Res       Date:  2017-09-25

5.  An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature.

Authors:  Kosuke Miki; Naoshi Obara; Kenichi Makishima; Tatsuhiro Sakamoto; Manabu Kusakabe; Takayasu Kato; Naoki Kurita; Hidekazu Nishikii; Yasuhisa Yokoyama; Mamiko Sakata-Yanagimoto; Yuichi Hasegawa; Shigeru Chiba
Journal:  Case Rep Hematol       Date:  2018-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.